PTHS AMEX
Pelthos Therapeutics Inc.
1W: +4.2%
1M: +17.9%
3M: +22.5%
YTD: -8.0%
$27.11
+0.11 (+0.41%)
Weekly Expected Move ±6.5%
$23
$25
$27
$28
$30
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$17.6M
52W Range9-54.29
Volume58,586
Avg Volume13,362
Beta3.33
Dividend—
Analyst Ratings
Company Info
CEOScott Plesha
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2025-07-02
Websitepelthos.com
4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703
Durham, NC 27703
US
Durham, NC 27703
US
877 265 8266
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Latest News
Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Pelthos Therapeutics names John M. Gay as CFO
Pelthos Therapeutics Announces CFO Transition
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Richard Malamut Sells 590 Shares of Stock
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Friedberg Ezra M | F-InKind | 144 | $27.01 | 2026-05-14 |
| GAY JOHN M. | 93,000 | $13.50 | 2026-04-20 | |
| GAY JOHN M. | 0 | — | 2026-04-10 | |
| Malamut Richard | S-Sale | 310 | $20.51 | 2026-04-02 |
| Malamut Richard | S-Sale | 280 | $21.36 | 2026-04-02 |